Sex (f/m) | Â | 58/1 |
Mean age (y, range) | 57.4 (32 - 80) | |
Age ≤ 60y |  | 63 % (n = 37) |
Hormone receptor positive | 83 % (n = 49) | |
Her2 neu positive (triple) | 34 % (n = 20) | |
Grading (1/2/3/ not available) | 7 % (n = 4)/ 44 % (n = 26)/36 % (n = 21)/13 % (n = 8) | |
Median time from first BC diagnosis to diagnosis of liver metastases (mo, range) | 45 (0 – 335.4) | |
Median time from diagnosis of liver metastases to first interventional treatment (mo, range) | 22 (1 - 294) | |
Mean number of liver metastases (n, range) | 13 (1 - 88) | |
Mean maximum diameter of liver metastases (cm, range) | 4.9 (1 - 14) | |
Mean liver volume (mL, range) | 1445 (801 - 2202) | |
Mean volume of liver metastases (mL, range) | 129.6 (0.5 - 976) | |
Mean tumor load (%, range) | 8.2 (0.1 - 51.4) | |
Extrahepatic metastases | 49 % (n = 29) | |
 | Bone only | n = 19 |
 | Bone | n = 24 |
 | Lung | n = 6 |
 | Lymphatic nodes (others than axillary) | n = 4 |
 | Peritoneum | n = 1 |